Cancer drug discovery and development

• Material Type: 図書
• Title: Cancer drug discovery and development
• Publication, Distribution, etc.: Humana
• Alternative Title: CDDD
• Place of Publication (Country Code): us
• Target Audience: 一般
• Note (General): Humana Press was acquired by Springer Science+Business Media in the fall of 2006 and continues to publish under the Humana Press imprint.
• Related Material: Platinum and other heavy metal compounds in cancer chemotherapy : molecular mechanisms and clinical applications; https://cir.nii.ac.jp/crid/1130000793721690880; COX-2 blockade in cancer prevention and therapy; https://cir.nii.ac.jp/crid/1130000793870561152; Anticancer drug development guide : preclinical screening, clinical trials, and approval; https://cir.nii.ac.jp/crid/1130000793980082432; Proteasome inhibitors in cancer therapy; https://cir.nii.ac.jp/crid/1130000794527768448; Drug delivery systems in cancer therapy; https://cir.nii.ac.jp/crid/1130000794945306368; Platinum-based drugs in cancer therapy; https://cir.nii.ac.jp/crid/1130000794953446784; Matrix metalloproteinase inhibitors in cancer therapy; https://cir.nii.ac.jp/crid/1130000795036226816; Nucleic acid therapeutics in cancer; https://cir.nii.ac.jp/crid/1130000795348552320; Cytokines in the genesis and treatment of cancer; https://cir.nii.ac.jp/crid/1130000795480920576; DNA and histone methylation as cancer targets; https://cir.nii.ac.jp/crid/1130000795498727680; Natural killer T cells : balancing the regulation of tumor immunity; https://cir.nii.ac.jp/crid/1130000795552775168; Advances in DNA repair in cancer therapy; https://cir.nii.ac.jp/crid/1130000795772546304; Signaling networks and cell cycle control : the molecular basis of cancer and other diseases; https://cir.nii.ac.jp/crid/1130000795803103360; Bladder tumors : molecular aspects and clinical management; https://cir.nii.ac.jp/crid/1130000795810230912; Apoptosis, senescence, and cancer; https://cir.nii.ac.jp/crid/1130000795835360512; Gene therapy for cancer; https://cir.nii.ac.jp/crid/1130000795860562304; Hormone therapy in breast and prostate cancer; https://cir.nii.ac.jp/crid/1130000796529443712; Cancer drug resistance; https://cir.nii.ac.jp/crid/1130000796633443328; Apoptosis and cancer chemotherapy; https://cir.nii.ac.jp/crid/1130000796684574592; Cell cycle inhibitors in cancer therapy : current strategies; https://cir.nii.ac.jp/crid/1130000797019595520; https://cir.nii.ac.jp/crid/1130000797045538816; Tumor targeting in cancer therapy; https://cir.nii.ac.jp/crid/1130000797877686912; Antiangiogenic agents in cancer therapy; https://cir.nii.ac.jp/crid/1130282268690182784; Tumor suppressor genes in human cancer; https://cir.nii.ac.jp/crid/1130282268697868416; Chemoradiation in cancer therapy; https://cir.nii.ac.jp/crid/1130282268880413568; Antibody-drug conjugates and immunotoxins : from pre-clinical development to therapeutic applications; https://cir.nii.ac.jp/crid/1130282268997637888; Targets for cancer chemotherapy : transcription factors and other nuclear proteins; https://cir.nii.ac.jp/crid/1130282269019614336; Molecular targeting in oncology; https://cir.nii.ac.jp/crid/1130282269054551808; https://cir.nii.ac.jp/crid/1130282269083102464; Oncogene-directed therapies; https://cir.nii.ac.jp/crid/1130282269140157056; Sensitization of cancer cells for chemo/immuno/radio-therapy; https://cir.nii.ac.jp/crid/1130282269191914752; Telomeres and telomerase in cancer; https://cir.nii.ac.jp/crid/1130282269457407872; Promising cancer chemopreventive agents; https://cir.nii.ac.jp/crid/1130282269484758656; Macromolecular anticancer therapeutics; https://cir.nii.ac.jp/crid/1130282269896232192; Camptothecins in cancer therapy; https://cir.nii.ac.jp/crid/1130282270021538432; mTOR pathway and mTOR inhibitors in cancer therapy; https://cir.nii.ac.jp/crid/1130282270818178176; Cancer therapeutics : experimental and clinical agents; https://cir.nii.ac.jp/crid/1130282270875532672; Stem cells and cancer; https://cir.nii.ac.jp/crid/1130282270942492032; Tumor models in cancer research; https://cir.nii.ac.jp/crid/1130282271241244672; Genomics and pharmacogenomics in anticancer drug development and clinical response; https://cir.nii.ac.jp/crid/1130282271315700608; Histone deacetylases : transcriptional regulation and other cellular functions; https://cir.nii.ac.jp/crid/1130282271337450752; Non-Hodgkin lymphoma : prognostic factors and targets; https://cir.nii.ac.jp/crid/1130282271463805824; Handbook of cancer vaccines; https://cir.nii.ac.jp/crid/1130282271680098560; DNA repair in cancer therapy; https://cir.nii.ac.jp/crid/1130282272060600832; Nuclear signaling pathways and targeting transcription in cancer; https://cir.nii.ac.jp/crid/1130282272566164864; Protein tyrosine kinases : from inhibitors to useful drugs; https://cir.nii.ac.jp/crid/1130282272728576384; Handbook of anticancer pharmacokinetics and pharmacodynamics; https://cir.nii.ac.jp/crid/1130282272872542976; The role of microtubules in cell biology, neurobiology, and oncology; https://cir.nii.ac.jp/crid/1130282273243573120
• Related Material (URI): https://ci.nii.ac.jp/ncid/BA36585533#entity
• Data Provider (Database): 国立情報学研究所 : CiNii Research
• Original Data Provider (Database): CiNii Books; https://ci.nii.ac.jp/books
• NCID: https://ci.nii.ac.jp/ncid/BA36585533 : BA36585533

Table of Contents

Platinum and other heavy metal compounds in cancer chemotherapy : molecular mechanisms and clinical applications

COX-2 blockade in cancer prevention and therapy

Anticancer drug development guide : preclinical screening, clinical trials, and approval

Proteasome inhibitors in cancer therapy

Drug delivery systems in cancer therapy